EpimAb Biotherapeutics Raises $25M In Series A Financing From International Consortium To Advance Pipeline Of Novel Bispecific Antibodies – biolegacy

EpimAb Biotherapeutics Raises $25M In Series A Financing From International Consortium To Advance Pipeline Of Novel Bispecific Antibodies

Post author:Sam
Post published:April 24, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace